Alkermes director reports RSU and option awards

Alkermes plc director Christopher I. Wright reported several compensation-related equity transactions.

Rhea-AI Filing Summary

Alkermes plc director Christopher I. Wright reported several compensation-related equity transactions. On May 21, 2026, 6,142 restricted stock units were exercised into ordinary shares, with 1,475 shares withheld at $36.95 per share to cover tax obligations rather than sold on the market. Wright also received new awards on May 20, 2026: 5,409 restricted stock units and 11,538 non-qualified stock options with a $36.98 exercise price, expiring on May 20, 2036. Following these transactions, he holds 27,680 ordinary shares directly. Footnotes clarify each restricted stock unit converts into one ordinary share and that the new awards vest in full around the next annual general meeting.

Insider Trade Summary

6,142 shares exercised/converted

Exercise 5 txns

Insider Wright Christopher I

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit Award	6,142	$0.00	$0.00
Exercise	Ordinary Shares	6,142	$0.00	$0.00
Exercise Price or Tax Liability	Ordinary Shares	1,475	$36.95	$55K
Grant/Award	Non Qualified Stock Option (Right to Buy)	11,538	$0.00	$0.00
Grant/Award	Restricted Stock Unit Award	5,409	$0.00	$0.00

Holdings After Transaction: Non Qualified Stock Option (Right to Buy) — 11,538 contracts (Direct); Restricted Stock Unit Award — 5,409 contracts (Direct); Ordinary Shares — 27,680 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents a contingent right to receive one ordinary share.
2. F2. Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
3. F3. This award is fully vested in accordance with its terms.

Key Figures

Tax-withholding shares: 1,475 shares at $36.95 RSUs exercised: 6,142 units RSUs granted: 5,409 units +3 more

6 metrics

Tax-withholding shares 1,475 shares at $36.95 Shares withheld to cover tax liability on May 21, 2026

RSUs exercised 6,142 units Restricted stock units converted into ordinary shares on May 21, 2026

RSUs granted 5,409 units New restricted stock unit award on May 20, 2026

Options granted 11,538 options at $36.98 Non-qualified stock option award on May 20, 2026

Post-transaction holdings 27,680 shares Ordinary shares held directly after tax-withholding transaction

Option expiration May 20, 2036 Expiry of non-qualified stock options granted May 20, 2026

Key Terms

Restricted Stock Unit, Non Qualified Stock Option (Right to Buy), tax-withholding disposition, derivative security

4 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one ordinary share."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Non Qualified Stock Option (Right to Buy) financial

"Non Qualified Stock Option (Right to Buy) with a $36.98 exercise price expiring May 20, 2036."

tax-withholding disposition financial

"Payment of exercise price or tax liability by delivering securities, a tax-withholding disposition."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

derivative security financial

"Exercise or conversion of derivative security involving restricted stock unit awards."

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Alkermes (ALKS) director Christopher Wright receive in this Form 4?

Christopher Wright received 5,409 restricted stock units and 11,538 non-qualified stock options. The options carry a $36.98 exercise price and are exercisable for Alkermes ordinary shares, reflecting routine director equity compensation grants.

How many Alkermes (ALKS) shares did Christopher Wright acquire through RSU vesting?

Wright’s Form 4 shows 6,142 restricted stock units converted into ordinary shares. Each restricted stock unit represents a contingent right to receive one ordinary share, so full vesting of that award delivered 6,142 Alkermes ordinary shares before tax withholding.

Were any Alkermes (ALKS) shares sold by Christopher Wright in this Form 4 filing?

The filing shows 1,475 ordinary shares disposed at $36.95 per share as a tax-withholding transaction. These shares were withheld to satisfy tax liabilities on equity awards and do not represent an open-market sale initiated by Wright.

What are the key terms of Christopher Wright’s new Alkermes (ALKS) stock options?

Wright received 11,538 non-qualified stock options with a $36.98 exercise price, each for one ordinary share. The options expire on May 20, 2036, providing a long-dated opportunity to purchase Alkermes shares if exercised.

How many Alkermes (ALKS) shares does Christopher Wright hold after these transactions?

After the reported transactions, Wright directly holds 27,680 Alkermes ordinary shares. This figure reflects his position following RSU vesting, tax withholding, and other equity movements disclosed in the Form 4 filing.

When do Christopher Wright’s new Alkermes (ALKS) equity awards vest?

The filing states that shares subject to the new awards vest in full on the earlier of the one-year anniversary of the grant date or the next annual general meeting that occurs at least 50 weeks after the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 08:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Christopher I

(Last) (First) (Middle)

CONNAUGHT HOUSE

1 BURLINGTON ROAD

(Street)

DUBLIN 4 Ireland

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/21/2026		M		6,142	A	(1)	29,155	D
Ordinary Shares	05/21/2026		F		1,475	D	$36.95	27,680	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non Qualified Stock Option (Right to Buy)	$36.98	05/20/2026		A		11,538		(2)	05/20/2036	Ordinary Shares	11,538	$0	11,538	D
Restricted Stock Unit Award	(1)	05/20/2026		A		5,409		(2)	(2)	Ordinary Shares	5,409	$0	5,409	D
Restricted Stock Unit Award	(1)	05/21/2026		M			6,142	(3)	(3)	Ordinary Shares	6,142	(1)	0	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one ordinary share.

2. Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.

3. This award is fully vested in accordance with its terms.

	/s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)